経口臨床栄養市場規模、シェア、動向分析レポート：ステージ別、適応症別、販売チャネル別、地域別、セグメント予測、2025年～2030年

経口臨床栄養市場の成長と動向：

Grand View Research, Inc.の新しいレポートによると、世界の経口臨床栄養市場規模は、2025年から2030年にかけてCAGR 5.0％を記録し、2030年までに229億7,000万米ドルに達すると推定されています。

経口臨床栄養は、電解質、タンパク質、繊維、エネルギー、ビタミン、ミネラルなど、栄養不足の人々に不可欠なサプリメントです。これは、食欲不振、食事摂取量の低下、病気などが原因です。これらの栄養製品は、粉末、液体、プリン、食物繊維、デザート、ジュース、ヨーグルトなど、経口摂取が可能な形態で販売されています。また、がん、神経疾患、胃腸障害などの慢性疾患の治療にも幅広く応用されています。

主要な市場企業は、世界市場の成長に寄与する新規製品の上市に関与しています。例えば、2018年4月、Abbott社は、タンパク質欠乏症のある50歳以上の人向けの飲料Ensure Protein Max with 2を発売しました。この飲料は30gのタンパク質と150キロカロリー、9種類のアミノ酸を含み、2種類のフレーバーがあります。この飲料には1gの糖分とビタミンD、C、Eなど22種類のビタミン・ミネラルが添加されています。

有力な市場企業はまた、製品ポートフォリオを強化し、企業の栄養ポートフォリオを改善し、臨床栄養分析を研究するために、コラボレーション、合併、買収に従事しています。これは世界市場にプラスの影響を与えています。例えば、2018年1月、Filament BioSolutions, Inc.は、IBDにおけるミクロベースの精密栄養の臨床応用を分析・研究することを目的としたプロジェクトで、CHEO, OttawaおよびOttawa Universityと戦略的提携を結びました。このプロジェクトはCIHRとゲノム・カナダから資金援助を受けています。

さらに、健康的なライフスタイルや、体の免疫力を向上させ健康で健康的な生活を送るための栄養価の高い食事の摂取に対する人々の意識が高まっています。それに伴い、がんなどの慢性疾患の有病率も上昇しています。調査によると、臨床治療の副作用による食欲不振や栄養失調が観察されています。このため、研究者は臨床治療の副作用に対抗するために栄養価を高めることで、経口臨床栄養サプリメントの処方に従事しています。これは市場全体の成長に役立っています。政府と民間組織は、研究開発とヘルスケア部門を改善することによって栄養不良の問題に対応するために投資と資金調達を行っています。例えば、2022年9月、バイデン-ハリス政権は、糖尿病、高血圧、肥満などの疾患による栄養不足に関連する食料と適切な食生活の問題を解決するために、アメリカにおける飢餓、栄養、健康に関するホワイトハウス会議を開催しました。この会議では、食品の栄養成分を改善し、健康的な生活を促進するために、政府が食品栄養産業に40億米ドル以上を投資することが発表されました。このような取り組みにより、より高度で効果的な経口臨床栄養サプリメントが開発され、市場での採用と成長が増加しています。

さらに、COVID-19パンデミックは経口臨床栄養市場にプラスの影響を与えています。経口臨床栄養サプリメントの需要は、栄養不良によって直面する問題に対応して増加しています。身体の免疫力を向上させるため、人々は栄養価の高い食品やビタミン、繊維、タンパク質が豊富なサプリメントを摂取するようになりました。しかも、これらのサプリメントは簡単に摂取できます。そのため、これらの製品の世界の販売は近年増加しています。市場企業はまた、品質と規制認定を受けた食品サプリメントに対する需要の高まりに対応するため、食品・栄養部門の製造能力を強化し始めています。

経口臨床栄養市場レポートハイライト

• 2024年には、慢性疾患の罹患率の増加、および健康状態や栄養不足を改善するために経口摂取される臨床栄養の利点に関する意識の高まりにより、成人向け分野が市場の大半のシェアを占めました。
• がん治療分野は、がん治療のための有病率と入院率の上昇に起因して、2024年に最大のシェアを保持しました。
• 2024年に最大のシェアを占めたのは機関販売でした。入院患者数の増加と長期ケアセンターなどのヘルスケア施設の世界の増加が、このセグメントの成長をさらに促進しています。
• 北米が2024年に最大のシェアを占めました。これは、老人人口の多さ、慢性疾患の負担、医療に対する公的・私的支出の多さなどの要因によるものです。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 経口臨床栄養市場の変数、動向、範囲

• 価格分析
• 業界分析
  • ユーザーの視点分析
  • 主要なエンドユーザー
• テクノロジー展望
• 規制の枠組み
• 市場系統の見通し
  • 親市場の見通し
• 市場力学
  • 市場促進要因分析
  • 市場抑制要因分析
  • 市場機会分析
  • 市場課題分析
• 経口臨床栄養市場分析ツール
  • 業界分析- ポーターのファイブフォース分析
  • PESTEL分析
• 価格分析
• COVID-19の影響

第4章 経口臨床栄養市場：ステージ別推定・動向分析

• 世界の経口臨床栄養市場：ステージ別ダッシュボード
• ステージ別市場シェア分析、2024年と2030年
• 経口臨床栄養市場：ステージ別、2018年～2030年
• 大人
• 小児

第5章 経口臨床栄養市場：適応症別推定・動向分析

• 世界の経口臨床栄養市場：適応症別ダッシュボード
• 適応症別市場シェア分析、2024年と2030年
• 経口臨床栄養市場：適応症別、2018年～2030年
• アルツハイマー病
• 栄養不足
• がんケア
• 糖尿病
• 慢性腎臓病
• 希少疾患
• 嚥下障害
• 疼痛管理
• 吸収不良/消化管障害/下痢
• その他

第6章 経口臨床栄養市場： 販売チャネル別の推定・動向分析

• 世界の経口臨床栄養市場：販売チャネル別ダッシュボード
• 販売チャネル別市場シェア分析、2024年と2030年
• 経口臨床栄養市場：販売チャネル別、2018年～2030年
• オンライン販売
• 小売売上高
• 機関投資家向け販売

第7章 経口臨床栄養市場：地域別推定・動向分析

• 地域別ダッシュボード
• 市場規模と予測動向分析、2018年～2030年
• 北米
  • 米国
  • カナダ
  • メキシコ
• 欧州
  • 英国
  • ドイツ
  • フランス
  • イタリア
  • スペイン
  • デンマーク
  • スウェーデン
  • ノルウェー
• アジア太平洋
  • 日本
  • 中国
  • インド
  • 韓国
  • タイ
  • オーストラリア
• ラテンアメリカ
  • ブラジル
  • アルゼンチン
• 中東・アフリカ
  • 南アフリカ
  • サウジアラビア
  • アラブ首長国連邦
  • クウェート

第8章 競合情勢

• 企業市場シェア分析、2024年
• 企業ヒートマップ分析
• 企業/競合の分類
• 企業プロファイル
  • Fresenius Kabi AG
  • Abbott Laboratories
  • Pfizer Inc.
  • Bayer AG
  • Nestle SA
  • GlaxoSmithKline plc
  • Baxter International Inc.
  • Otsuka Holdings Co., Ltd.
  • Mead Johnson &Company, LLC
  • Danone（Nutricia）
  • B. Braun Melsungen AG.
  • Kate Farms, Inc.
  • Medline Industries, LP

List of Tables

• Table 1 List of secondary sources
• Table 2 List of abbreviations
• Table 3 North America oral clinical nutrition market estimates and forecasts, by stage, 2018 - 2030 (USD Million)
• Table 4 North America oral clinical nutrition market estimates and forecasts, by indication, 2018 - 2030 (USD Million)
• Table 5 North America oral clinical nutrition market estimates and forecasts by sales channel, 2018 - 2030 (USD Million)
• Table 6 U.S oral clinical nutrition market estimates and forecasts, by stage, 2018 - 2030 (USD Million)
• Table 7 U.S oral clinical nutrition market estimates and forecasts, by indication, 2018 - 2030 (USD Million)
• Table 8 U.S oral clinical nutrition market estimates and forecasts by sales channel, 2018 - 2030 (USD Million)
• Table 9 Canada oral clinical nutrition market estimates and forecasts, by stage, 2018 - 2030 (USD Million)
• Table 10 Canada oral clinical nutrition market estimates and forecasts, by indication, 2018 - 2030 (USD Million)
• Table 11 Canada oral clinical nutrition market estimates and forecasts by sales channel, 2018 - 2030 (USD Million)
• Table 12 Mexico oral clinical nutrition market estimates and forecasts, by stage, 2018 - 2030 (USD Million)
• Table 13 Mexico oral clinical nutrition market estimates and forecasts, by indication, 2018 - 2030 (USD Million)
• Table 14 Mexico oral clinical nutrition market estimates and forecasts by sales channel, 2018 - 2030 (USD Million)
• Table 15 Europe oral clinical nutrition market estimates and forecasts, by stage, 2018 - 2030 (USD Million)
• Table 16 Europe oral clinical nutrition market estimates and forecasts, by indication, 2018 - 2030 (USD Million)
• Table 17 Europe oral clinical nutrition market estimates and forecasts by sales channel, 2018 - 2030 (USD Million)
• Table 18 UK oral clinical nutrition market estimates and forecasts, by stage, 2018 - 2030 (USD Million)
• Table 19 UK oral clinical nutrition market estimates and forecasts, by indication, 2018 - 2030 (USD Million)
• Table 20 UK oral clinical nutrition market estimates and forecasts by sales channel, 2018 - 2030 (USD Million)
• Table 21 Germany oral clinical nutrition market estimates and forecasts, by stage, 2018 - 2030 (USD Million)
• Table 22 Germany oral clinical nutrition market estimates and forecasts, by indication, 2018 - 2030 (USD Million)
• Table 23 Germany oral clinical nutrition market estimates and forecasts by sales channel, 2018 - 2030 (USD Million)
• Table 24 France oral clinical nutrition market estimates and forecasts, by stage, 2018 - 2030 (USD Million)
• Table 25 France oral clinical nutrition market estimates and forecasts, by indication, 2018 - 2030 (USD Million)
• Table 26 France oral clinical nutrition market estimates and forecasts by sales channel, 2018 - 2030 (USD Million)
• Table 27 Italy oral clinical nutrition market estimates and forecasts, by stage, 2018 - 2030 (USD Million)
• Table 28 Italy oral clinical nutrition market estimates and forecasts, by indication, 2018 - 2030 (USD Million)
• Table 29 Italy oral clinical nutrition market estimates and forecasts by sales channel, 2018 - 2030 (USD Million)
• Table 30 Spain oral clinical nutrition market estimates and forecasts, by stage, 2018 - 2030 (USD Million)
• Table 31 Spain oral clinical nutrition market estimates and forecasts, by indication, 2018 - 2030 (USD Million)
• Table 32 Spain oral clinical nutrition market estimates and forecasts by sales channel, 2018 - 2030 (USD Million)
• Table 33 Sweden oral clinical nutrition market estimates and forecasts, by stage, 2018 - 2030 (USD Million)
• Table 34 Sweden oral clinical nutrition market estimates and forecasts, by indication, 2018 - 2030 (USD Million)
• Table 35 Sweden oral clinical nutrition market estimates and forecasts by sales channel, 2018 - 2030 (USD Million)
• Table 36 Denmark oral clinical nutrition market estimates and forecasts, by stage, 2018 - 2030 (USD Million)
• Table 37 Denmark oral clinical nutrition market estimates and forecasts, by indication, 2018 - 2030 (USD Million)
• Table 38 Denmark oral clinical nutrition market estimates and forecasts by sales channel, 2018 - 2030 (USD Million)
• Table 39 Norway oral clinical nutrition market estimates and forecasts, by stage, 2018 - 2030 (USD Million)
• Table 40 Norway oral clinical nutrition market estimates and forecasts, by indication, 2018 - 2030 (USD Million)
• Table 41 Norway oral clinical nutrition market estimates and forecasts by sales channel, 2018 - 2030 (USD Million)
• Table 42 Asia Pacific oral clinical nutrition market estimates and forecasts, by stage, 2018 - 2030 (USD Million)
• Table 43 Asia Pacific oral clinical nutrition market estimates and forecasts, by indication, 2018 - 2030 (USD Million)
• Table 44 Asia Pacific oral clinical nutrition market estimates and forecasts by sales channel, 2018 - 2030 (USD Million)
• Table 45 Japan oral clinical nutrition market estimates and forecasts, by stage, 2018 - 2030 (USD Million)
• Table 46 Japan oral clinical nutrition market estimates and forecasts, by indication, 2018 - 2030 (USD Million)
• Table 47 Japan oral clinical nutrition market estimates and forecasts by sales channel, 2018 - 2030 (USD Million)
• Table 48 China oral clinical nutrition market estimates and forecasts, by stage, 2018 - 2030 (USD Million)
• Table 49 China oral clinical nutrition market estimates and forecasts, by indication, 2018 - 2030 (USD Million)
• Table 50 China oral clinical nutrition market estimates and forecasts by sales channel, 2018 - 2030 (USD Million)
• Table 51 India oral clinical nutrition market estimates and forecasts, by stage, 2018 - 2030 (USD Million)
• Table 52 India oral clinical nutrition market estimates and forecasts, by indication, 2018 - 2030 (USD Million)
• Table 53 India oral clinical nutrition market estimates and forecasts by sales channel, 2018 - 2030 (USD Million)
• Table 54 Australia oral clinical nutrition market estimates and forecasts, by stage, 2018 - 2030 (USD Million)
• Table 55 Australia oral clinical nutrition market estimates and forecasts, by indication, 2018 - 2030 (USD Million)
• Table 56 Australia oral clinical nutrition market estimates and forecasts by sales channel, 2018 - 2030 (USD Million)
• Table 57 South Korea oral clinical nutrition market estimates and forecasts, by stage, 2018 - 2030 (USD Million)
• Table 58 South Korea oral clinical nutrition market estimates and forecasts, by indication, 2018 - 2030 (USD Million)
• Table 59 Thailand oral clinical nutrition market estimates and forecasts, by stage, 2018 - 2030 (USD Million)
• Table 60 Thailand oral clinical nutrition market estimates and forecasts, by indication, 2018 - 2030 (USD Million)
• Table 61 Thailand oral clinical nutrition market estimates and forecasts by sales channel, 2018 - 2030 (USD Million)
• Table 62 Latin America oral clinical nutrition market estimates and forecasts, by stage, 2018 - 2030 (USD Million)
• Table 63 Latin America oral clinical nutrition market estimates and forecasts, by indication, 2018 - 2030 (USD Million)
• Table 64 Latin America oral clinical nutrition market estimates and forecasts by sales channel, 2018 - 2030 (USD Million)
• Table 65 Brazil oral clinical nutrition market estimates and forecasts, by stage, 2018 - 2030 (USD Million)
• Table 66 Brazil oral clinical nutrition market estimates and forecasts, by indication, 2018 - 2030 (USD Million)
• Table 67 Brazil oral clinical nutrition market estimates and forecasts by sales channel, 2018 - 2030 (USD Million)
• Table 68 Argentina oral clinical nutrition market estimates and forecasts, by stage, 2018 - 2030 (USD Million)
• Table 69 Argentina oral clinical nutrition market estimates and forecasts, by indication, 2018 - 2030 (USD Million)
• Table 70 Argentina oral clinical nutrition market estimates and forecasts by sales channel, 2018 - 2030 (USD Million)
• Table 71 MEA oral clinical nutrition market estimates and forecasts, by stage, 2018 - 2030 (USD Million)
• Table 72 MEA oral clinical nutrition market estimates and forecasts, by indication, 2018 - 2030 (USD Million)
• Table 73 MEA oral clinical nutrition market estimates and forecasts by sales channel, 2018 - 2030 (USD Million)
• Table 74 South Africa oral clinical nutrition market estimates and forecasts, by stage, 2018 - 2030 (USD Million)
• Table 75 South Africa oral clinical nutrition market estimates and forecasts, by indication, 2018 - 2030 (USD Million)
• Table 76 South Africa oral clinical nutrition market estimates and forecasts by sales channel, 2018 - 2030 (USD Million)
• Table 77 Saudi Arabia oral clinical nutrition market estimates and forecasts, by stage, 2018 - 2030 (USD Million)
• Table 78 Saudi Arabia oral clinical nutrition market estimates and forecasts, by indication, 2018 - 2030 (USD Million)
• Table 79 Saudi Arabia oral clinical nutrition market estimates and forecasts by sales channel, 2018 - 2030 (USD Million)
• Table 80 UAE oral clinical nutrition market estimates and forecasts, by stage, 2018 - 2030 (USD Million)
• Table 81 UAE oral clinical nutrition market estimates and forecasts, by indication, 2018 - 2030 (USD Million)
• Table 82 UAE oral clinical nutrition market estimates and forecasts by sales channel, 2018 - 2030 (USD Million)

List of Figures

• Fig. 1 Oral Clinical Nutrition Market Segmentation
• Fig. 2 Information Procurement
• Fig. 3 Data Analysis Models
• Fig. 4 Market Formulation and Validation
• Fig. 5 Data Validating & Publishing
• Fig. 6 Market Snapshot
• Fig. 7 Segment Snapshot (1/2)
• Fig. 8 Segment Snapshot (2/2)
• Fig. 9 Competitive Landscape Snapshot
• Fig. 10 Oral Clinical Nutrition - Market Size and Growth Prospects (USD Million)
• Fig. 11 Oral Clinical Nutrition Market: Industry Value Chain Analysis
• Fig. 12 Oral Clinical Nutrition Market: Market Dynamics
• Fig. 13 Oral Clinical Nutrition Market: PORTER's Analysis
• Fig. 14 Oral Clinical Nutrition Market: PESTEL Analysis
• Fig. 15 Oral Clinical Nutrition Market: Stage Movement Analysis, 2018 - 2030 (USD Million)
• Fig. 16 Oral Clinical Nutrition Market Share Analysis by Stage, 2024 & 2030
• Fig. 17 Adults Market Estimates & Forecasts, 2018 - 2030 (Revenue, USD Million)
• Fig. 18 Pediatrics Market Estimates & Forecasts, 2018 - 2030 (Revenue, USD Million)
• Fig. 19 Oral Clinical Nutrition Market: Indication Movement Analysis, 2018 - 2030 (USD Million)
• Fig. 20 Oral Clinical Nutrition Market Share Analysis by Indication , 2024 & 2030
• Fig. 21 Alzheimer's Market Estimates & Forecasts, 2018 - 2030 (Revenue, USD Million)
• Fig. 22 Nutrition Deficiency Market Estimates & Forecasts, 2018 - 2030 (Revenue, USD Million)
• Fig. 23 Cancer Care Market Estimates & Forecasts, 2018 - 2030 (Revenue, USD Million)
• Fig. 24 Diabetes Market Estimates & Forecasts, 2018 - 2030 (Revenue, USD Million)
• Fig. 25 Chronic Kidney Diseases Market Estimates & Forecasts, 2018 - 2030 (Revenue, USD Million)
• Fig. 26 Orphan Diseases Market Estimates & Forecasts, 2018 - 2030 (Revenue, USD Million)
• Fig. 27 DysphagiaMarket Estimates & Forecasts, 2018 - 2030 (Revenue, USD Million)
• Fig. 28 Pain Management Market Estimates & Forecasts, 2018 - 2030 (Revenue, USD Million)
• Fig. 29 Malabsorption/GI Disorder/Diarrhea Market Estimates & Forecasts, 2018 - 2030 (Revenue, USD Million)
• Fig. 30 Others Market Estimates & Forecasts, 2018 - 2030 (Revenue, USD Million)
• Fig. 31 Oral Clinical Nutrition Market: Sales Channel Movement Analysis, 2018 - 2030 (USD Million)
• Fig. 32 Oral Clinical Nutrition Market Share Analysis by Sales Channel, 2024 & 2030
• Fig. 33 Online Sales Market Estimates & Forecasts, 2018 - 2030 (Revenue, USD Million)
• Fig. 34 Retail Sales Market Estimates & Forecasts, 2018 - 2030 (Revenue, USD Million)
• Fig. 35 Institutional Sales Market Estimates & Forecasts, 2018 - 2030 (Revenue, USD Million)
• Fig. 36 Oral Clinical Nutrition Market Revenue, by Region, 2024 & 2030 (USD Million)
• Fig. 37 Regional Marketplace: Key Takeaways
• Fig. 38 North America Oral Clinical Nutrition Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 39 U.S Oral Clinical Nutrition Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 40 Canada Oral Clinical Nutrition Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 41 Mexico Oral Clinical Nutrition Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 42 Europe Oral Clinical Nutrition Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 43 UK Oral Clinical Nutrition Market Estimates and Forecasts, 2018 - 2030,) (USD Million)
• Fig. 44 Germany Oral Clinical Nutrition Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 45 France Oral Clinical Nutrition Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 46 Italy Oral Clinical Nutrition Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 47 Spain Oral Clinical Nutrition Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 48 Sweden Oral Clinical Nutrition Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 49 Denmark Oral Clinical Nutrition Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 50 Norway Oral Clinical Nutrition Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 51 Asia Pacific Oral Clinical Nutrition Market Estimates and Forecast, 2018 - 2030 (USD Million)
• Fig. 52 Japan Oral Clinical Nutrition Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 53 China Oral Clinical Nutrition Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 54 India Oral Clinical Nutrition Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 55 Australia Oral Clinical Nutrition Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 56 Thailand Oral Clinical Nutrition Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 57 Latin America Oral Clinical Nutrition Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 58 Brazil Oral Clinical Nutrition Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 59 Argentina Oral Clinical Nutrition Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 60 MEA Oral Clinical Nutrition Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 61 Saudi Arabia Oral Clinical Nutrition Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 62 UAE Oral Clinical Nutrition Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 63 South Africa Oral Clinical Nutrition Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 64 Kuwait Oral Clinical Nutrition Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 65 Key Company Categorization
• Fig. 66 Company Market Positioning
• Fig. 67 Key Company Market Share Analysis, 2024
• Fig. 68 Strategic Framework

Oral Clinical Nutrition Market Growth & Trends:

The global oral clinical nutrition market size is estimated to reach USD 22.97 billion by 2030, registering a CAGR of 5.0% from 2025 to 2030, according to a new report by Grand View Research, Inc., Oral clinical nutrition are the supplements such electrolytes, protein, fibre, energy, vitamins and minerals essential for the people with nutrient deficiency. This is due to poor appetite, low food intake and illness. These nutritional products are available in the form of powder, liquid, pudding, fiber, dessert, juices, yogurt and so on which can be consumed orally. They also have a wide range of applications in the treatment of chronic diseases such as cancer, neurological conditions and gastrointestinal disorders.

The key market players are involved in the novel product launch contributing to the global market growth. For instance, in April 2018, Abbott launched a beverage Ensure Protein Max with 2 for people over age 50+ having protein deficiency. The beverage contains 30g protein with 150 calories and 9 amino acids and available in two flavors. The beverage is supplemented with 1g sugar and 22 vitamins and minerals such as Vitamin D, C, and E. Such novel product launch by market players is expected to propel market growth.

Dominant market players are also engaged in collaborations, mergers, acquisitions to enhance the product portfolio and improvise the nutrition portfolio of the company and study the clinical nutrition analysis. This has a positive impact on the global market. For instance, in January 2018, Filament BioSolutions, Inc. entered into a strategic collaboration with CHEO, Ottawa and Ottawa University for a project designed to analyze and study the clinical application of microme-based precision nutrition in IBD. The project was funded by CIHR and Genome Canada.

Moreover, there is rising awareness among people regarding a healthy lifestyle, and consumption of a nutritious diet for improving the body's immunity and living a healthy and fit life. Along with this, there is a rising prevalence of chronic diseases such as cancer. According to the research, loss of appetite, and malnutrition is observed due to the side effects of the clinical treatment. Due to this, the researchers are engaged in formulating oral clinical nutrition supplements by enhancing their nutritional value to counter the side effects of the clinical treatment. This helps in the overall growth of the market. The government and private organizations are investing and raising funds to cater to the problems of malnutrition by improving the R&D and healthcare sector. For instance, in September 2022, Biden-Harris Administration held a White House Conference on Hunger, Nutrition and Health in America to solve the issues of food and proper diet related to nutrient deficiency due to diseases such as diabetes, hypertension, and obesity. The conference stated that over USD 4 billion will be invested by the government in the food nutrition industry to improve the nutritional content in the food and promote a healthy living. Such initiative has led to the development of more advanced and effective oral clinical nutrition supplements, which has increased their adoption and growth in the market.

Further, the COVID-19 pandemic has had a positive impact on the oral clinical nutrition market. The demand for oral clinical nutrition supplements has increased catering to the issues faced due to malnutrition. In order to improve the body's immunity, people have started consuming nutritious food, and supplements enriched with vitamins, fibers, and proteins. Moreover, these supplements are easy to consume. Thus, the global sale of these products has increased in recent years. Market players have also started enhancing the manufacturing capabilities of the food and nutrition departments to cater to the growing demand for quality and regulatory-certified food supplements.

Oral Clinical Nutrition Market Report Highlights:

• In 2024, the adult segment held a majority share of the market owing to the increasing incidence of chronic diseases as well as growing awareness about the advantages of clinical nutrition consumed orally to improve health conditions and nutrient deficiency.
• Cancer care segment held the largest share in 2024, owing to its rising prevalence and hospital admissions for cancer treatment.
• Institutional sales held the largest share in 2024. The rise in hospital admissions and a growing number of healthcare facilities such as long-term care centers globally is further driving the segment growth.
• North America held the largest share in 2024, owing to factors such as a large geriatric population, chronic disease burden, and high public & private expenditures on healthcare.

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
• 1.2. Segment Definitions
  • 1.2.1. Stage
  • 1.2.2. Indication
  • 1.2.3. Sales Channel
  • 1.2.4. Regional scope
  • 1.2.5. Estimates and forecasts timeline
• 1.3. Research Methodology
• 1.4. Information Procurement
  • 1.4.1. Purchased database
  • 1.4.2. GVR's internal database
  • 1.4.3. Secondary sources
  • 1.4.4. Primary research
  • 1.4.5. Details of primary research
• 1.5. Information or Data Analysis
  • 1.5.1. Data analysis models
• 1.6. Market Formulation & Validation
• 1.7. Model Details
  • 1.7.1. Commodity flow analysis (Model 1)
  • 1.7.2. Approach 1: Commodity flow approach
• 1.8. List of Secondary Sources
• 1.9. List of Primary Sources
• 1.10. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
  • 2.2.1. Stage outlook
  • 2.2.2. Indication outlook
  • 2.2.3. Sales Channel outlook
  • 2.2.4. Regional outlook
• 2.3. Competitive Insights

Chapter 3. Oral Clinical Nutrition Market Variables, Trends & Scope

• 3.1. Pricing Analysis
• 3.2. Industry Analysis
  • 3.2.1. User perspective analysis
  • 3.2.2. Key end users
• 3.3. Technology Outlook
• 3.4. Regulatory Framework
• 3.5. Market Lineage Outlook
  • 3.5.1. Parent market outlook
• 3.6. Market Dynamics
  • 3.6.1. Market driver analysis
    • 3.6.1.1. Rising geriatric population
    • 3.6.1.2. Growing prevalence of chronic diseases
    • 3.6.1.3. Increasing incidence of Cancer
    • 3.6.1.4. Increasing risk of malnutrition
    • 3.6.1.5. Shifting trend toward the consumption of disease-specific formulas
    • 3.6.1.6. Growing demand for neonatal and preterm enteral feeding
    • 3.6.1.7. Rising organizational strategic initiatives To enhance market presence
  • 3.6.2. Market restraint analysis
    • 3.6.2.1. Lack of awareness in the medical community
    • 3.6.2.2. Improper categorization of clinical nutrition
  • 3.6.3. Market opportunity analysis
  • 3.6.4. Market challenges analysis
• 3.7. Oral Clinical Nutrition Market Analysis Tools
  • 3.7.1. Industry Analysis - Porter's Five Forces
    • 3.7.1.1. Supplier power
    • 3.7.1.2. Buyer power
    • 3.7.1.3. Substitution threat
    • 3.7.1.4. Threat of new entrant
    • 3.7.1.5. Competitive rivalry
  • 3.7.2. PESTEL Analysis
    • 3.7.2.1. Political landscape
    • 3.7.2.2. Economic and Social landscape
    • 3.7.2.3. Technological landscape
    • 3.7.2.4. Environmental landscape
    • 3.7.2.5. Legal Landscape
• 3.8. Pricing Analysis
• 3.9. Covid-19 Impact

Chapter 4. Oral Clinical Nutrition Market: Stage Estimates & Trend Analysis

• 4.1. Global Oral Clinical Nutrition Market: Stage Dashboard
• 4.2. Stage Market Share Analysis, 2024 & 2030
• 4.3. Oral Clinical Nutrition Market: By Stage, 2018 to 2030
• 4.4. Adults
  • 4.4.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
• 4.5. Pediatrics
  • 4.5.1. Market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 5. Oral Clinical Nutrition Market: Indication Estimates & Trend Analysis

• 5.1. Global Oral Clinical Nutrition Market: Indication Dashboard
• 5.2. Indication Market Share Analysis, 2024 & 2030
• 5.3. Oral Clinical Nutrition Market: By Indication, 2018 to 2030
• 5.4. Alzheimer's
  • 5.4.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
• 5.5. Nutrition Deficiency
  • 5.5.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
• 5.6. Cancer Care
  • 5.6.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
• 5.7. Diabetes
  • 5.7.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
• 5.8. Chronic Kidney Diseases
  • 5.8.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
• 5.9. Orphan Diseases
  • 5.9.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
• 5.10. Dysphagia
  • 5.10.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
• 5.11. Pain Management
  • 5.11.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
• 5.12. Malabsorption/GI Disorder/Diarrhea
  • 5.12.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
• 5.13. Others
  • 5.13.1. Market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 6. Oral Clinical Nutrition Market: Sales Channel Estimates & Trend Analysis

• 6.1. Global Oral Clinical Nutrition Market: Sales Channel Dashboard
• 6.2. Sales Channel Market Share Analysis, 2024 & 2030
• 6.3. Oral Clinical Nutrition Market: By Sales Channel, 2018 to 2030
• 6.4. Online Sales
  • 6.4.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
• 6.5. Retail Sales
  • 6.5.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
• 6.6. Institutional Sales
  • 6.6.1. Market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 7. Oral Clinical Nutrition Market: Regional Estimates & Trend Analysis by stage, indication and sales channel

• 7.1. Regional Dashboard
• 7.2. Market Size & Forecasts Trend Analysis, 2018 to 2030:
• 7.3. North America
  • 7.3.1. U.S.
    • 7.3.1.1. Key country dynamics
    • 7.3.1.2. Regulatory framework/Reimbursement Scenario/Reimbursement Scenario
    • 7.3.1.3. Competitive scenario
    • 7.3.1.4. U.S. market estimates and forecasts, 2018 to 2030 (USD Million)
  • 7.3.2. Canada
    • 7.3.2.1. Key country dynamics
    • 7.3.2.2. Regulatory framework/Reimbursement Scenario
    • 7.3.2.3. Competitive scenario
    • 7.3.2.4. Canada market estimates and forecasts, 2018 to 2030 (USD Million)
  • 7.3.3. Mexico
    • 7.3.3.1. Key country dynamics
    • 7.3.3.2. Regulatory framework/Reimbursement Scenario
    • 7.3.3.3. Competitive scenario
    • 7.3.3.4. Mexico market estimates and forecasts, 2018 to 2030 (USD Million)
• 7.4. Europe
  • 7.4.1. UK
    • 7.4.1.1. Key country dynamics
    • 7.4.1.2. Regulatory framework/Reimbursement Scenario
    • 7.4.1.3. Competitive scenario
    • 7.4.1.4. UK market estimates and forecasts, 2018 to 2030 (USD Million)
  • 7.4.2. Germany
    • 7.4.2.1. Key country dynamics
    • 7.4.2.2. Regulatory framework/Reimbursement Scenario
    • 7.4.2.3. Competitive scenario
    • 7.4.2.4. Germany market estimates and forecasts, 2018 to 2030 (USD Million)
  • 7.4.3. France
    • 7.4.3.1. Key country dynamics
    • 7.4.3.2. Regulatory framework/Reimbursement Scenario
    • 7.4.3.3. Competitive scenario
    • 7.4.3.4. France market estimates and forecasts, 2018 to 2030 (USD Million)
  • 7.4.4. Italy
    • 7.4.4.1. Key country dynamics
    • 7.4.4.2. Regulatory framework/Reimbursement Scenario
    • 7.4.4.3. Competitive scenario
    • 7.4.4.4. Italy market estimates and forecasts, 2018 to 2030 (USD Million)
  • 7.4.5. Spain
    • 7.4.5.1. Key country dynamics
    • 7.4.5.2. Regulatory framework/Reimbursement Scenario
    • 7.4.5.3. Competitive scenario
    • 7.4.5.4. Spain market estimates and forecasts, 2018 to 2030 (USD Million)
  • 7.4.6. Denmark
    • 7.4.6.1. Key country dynamics
    • 7.4.6.2. Regulatory framework/Reimbursement Scenario
    • 7.4.6.3. Competitive scenario
    • 7.4.6.4. Denmark market estimates and forecasts, 2018 to 2030 (USD Million)
  • 7.4.7. Sweden
    • 7.4.7.1. Key country dynamics
    • 7.4.7.2. Regulatory framework/Reimbursement Scenario
    • 7.4.7.3. Competitive scenario
    • 7.4.7.4. Sweden market estimates and forecasts, 2018 to 2030 (USD Million)
  • 7.4.8. Norway
    • 7.4.8.1. Key country dynamics
    • 7.4.8.2. Regulatory framework/Reimbursement Scenario
    • 7.4.8.3. Competitive scenario
    • 7.4.8.4. Norway market estimates and forecasts, 2018 to 2030 (USD Million)
• 7.5. Asia Pacific
  • 7.5.1. Japan
    • 7.5.1.1. Key country dynamics
    • 7.5.1.2. Regulatory framework/Reimbursement Scenario
    • 7.5.1.3. Competitive scenario
    • 7.5.1.4. Japan market estimates and forecasts, 2018 to 2030 (USD Million)
  • 7.5.2. China
    • 7.5.2.1. Key country dynamics
    • 7.5.2.2. Regulatory framework/Reimbursement Scenario
    • 7.5.2.3. Competitive scenario
    • 7.5.2.4. China market estimates and forecasts, 2018 to 2030 (USD Million)
  • 7.5.3. India
    • 7.5.3.1. Key country dynamics
    • 7.5.3.2. Regulatory framework/Reimbursement Scenario
    • 7.5.3.3. Competitive scenario
    • 7.5.3.4. India market estimates and forecasts, 2018 to 2030 (USD Million)
  • 7.5.4. South Korea
    • 7.5.4.1. Key country dynamics
    • 7.5.4.2. Regulatory framework/Reimbursement Scenario
    • 7.5.4.3. Competitive scenario
    • 7.5.4.4. South Korea market estimates and forecasts, 2018 to 2030 (USD Million)
  • 7.5.5. Thailand
    • 7.5.5.1. Key country dynamics
    • 7.5.5.2. Regulatory framework/Reimbursement Scenario
    • 7.5.5.3. Competitive scenario
    • 7.5.5.4. Thailand market estimates and forecasts, 2018 to 2030 (USD Million)
  • 7.5.6. Australia
    • 7.5.6.1. Key country dynamics
    • 7.5.6.2. Regulatory framework/Reimbursement Scenario
    • 7.5.6.3. Competitive scenario
    • 7.5.6.4. Australia market estimates and forecasts, 2018 to 2030 (USD Million)
• 7.6. Latin America
  • 7.6.1. Brazil
    • 7.6.1.1. Key country dynamics
    • 7.6.1.2. Regulatory framework/Reimbursement Scenario
    • 7.6.1.3. Competitive scenario
    • 7.6.1.4. Brazil market estimates and forecasts, 2018 to 2030 (USD Million)
  • 7.6.2. Argentina
    • 7.6.2.1. Key country dynamics
    • 7.6.2.2. Regulatory framework/Reimbursement Scenario
    • 7.6.2.3. Competitive scenario
    • 7.6.2.4. Argentina market estimates and forecasts, 2018 to 2030 (USD Million)
• 7.7. MEA
  • 7.7.1. South Africa
    • 7.7.1.1. Key country dynamics
    • 7.7.1.2. Regulatory framework/Reimbursement Scenario
    • 7.7.1.3. Competitive scenario
    • 7.7.1.4. South Africa market estimates and forecasts, 2018 to 2030 (USD Million)
  • 7.7.2. Saudi Arabia
    • 7.7.2.1. Key country dynamics
    • 7.7.2.2. Regulatory framework/Reimbursement Scenario
    • 7.7.2.3. Competitive scenario
    • 7.7.2.4. Saudi Arabia market estimates and forecasts, 2018 to 2030 (USD Million)
  • 7.7.3. UAE
    • 7.7.3.1. Key country dynamics
    • 7.7.3.2. Regulatory framework/Reimbursement Scenario
    • 7.7.3.3. Competitive scenario
    • 7.7.3.4. UAE market estimates and forecasts, 2018 to 2030 (USD Million)
  • 7.7.4. Kuwait
    • 7.7.4.1. Key country dynamics
    • 7.7.4.2. Regulatory framework/Reimbursement Scenario
    • 7.7.4.3. Competitive scenario
    • 7.7.4.4. Kuwait market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 8. Competitive Landscape

• 8.1. Company Market Share Analysis, 2024
• 8.2. Company Heat Map Analysis
• 8.3. Company/Competition Categorization
• 8.4. Company Profiles
  • 8.4.1. Fresenius Kabi AG
    • 8.4.1.1. Overview
    • 8.4.1.2. Financial performance
    • 8.4.1.3. Product benchmarking
    • 8.4.1.4. Strategic initiatives
  • 8.4.2. Abbott Laboratories
    • 8.4.2.1. Overview
    • 8.4.2.2. Financial performance
    • 8.4.2.3. Product benchmarking
    • 8.4.2.4. Strategic initiatives
  • 8.4.3. Pfizer Inc.
    • 8.4.3.1. Overview
    • 8.4.3.2. Financial performance
    • 8.4.3.3. Product benchmarking
    • 8.4.3.4. Strategic initiatives
  • 8.4.4. Bayer AG
    • 8.4.4.1. Overview
    • 8.4.4.2. Financial performance
    • 8.4.4.3. Product benchmarking
    • 8.4.4.4. Strategic initiatives
  • 8.4.5. Nestle S.A.
    • 8.4.5.1. Overview
    • 8.4.5.2. Financial performance
    • 8.4.5.3. Product benchmarking
    • 8.4.5.4. Strategic initiatives
  • 8.4.6. GlaxoSmithKline plc
    • 8.4.6.1. Overview
    • 8.4.6.2. Financial performance
    • 8.4.6.3. Product benchmarking
    • 8.4.6.4. Strategic initiatives
  • 8.4.7. Baxter International Inc.
    • 8.4.7.1. Overview
    • 8.4.7.2. Financial performance
    • 8.4.7.3. Product benchmarking
    • 8.4.7.4. Strategic initiatives
  • 8.4.8. Otsuka Holdings Co., Ltd.
    • 8.4.8.1. Overview
    • 8.4.8.2. Financial performance
    • 8.4.8.3. Product benchmarking
    • 8.4.8.4. Strategic initiatives
  • 8.4.9. Mead Johnson & Company, LLC
    • 8.4.9.1. Overview
    • 8.4.9.2. Financial performance
    • 8.4.9.3. Product benchmarking
    • 8.4.9.4. Strategic initiatives
  • 8.4.10. Danone (Nutricia)
    • 8.4.10.1. Overview
    • 8.4.10.2. Financial performance
    • 8.4.10.3. Product benchmarking
    • 8.4.10.4. Strategic initiatives
  • 8.4.11. B. Braun Melsungen AG.
    • 8.4.11.1. Overview
    • 8.4.11.2. Financial performance
    • 8.4.11.3. Product benchmarking
    • 8.4.11.4. Strategic initiatives
  • 8.4.12. Kate Farms, Inc.
    • 8.4.12.1. Overview
    • 8.4.12.2. Financial performance
    • 8.4.12.3. Product benchmarking
    • 8.4.12.4. Strategic initiatives
  • 8.4.13. Medline Industries, LP
    • 8.4.13.1. Overview
    • 8.4.13.2. Financial performance
    • 8.4.13.3. Product benchmarking
    • 8.4.13.4. Strategic initiatives